Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease
- PMID: 24036007
- PMCID: PMC3865797
- DOI: 10.1016/j.jhep.2013.09.002
Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease
Abstract
Background & aims: With the increasing prevalence of liver disease worldwide, there is an urgent clinical need for reliable methods to diagnose and stage liver pathology. Liver biopsy, the current gold standard, is invasive and limited by sampling and observer dependent variability. In this study, we aimed to assess the diagnostic accuracy of a novel magnetic resonance protocol for liver tissue characterisation.
Methods: We conducted a prospective study comparing our magnetic resonance technique against liver biopsy. The individual components of the scanning protocol were T1 mapping, proton spectroscopy and T2* mapping, which quantified liver fibrosis, steatosis and haemosiderosis, respectively. Unselected adult patients referred for liver biopsy as part of their routine care were recruited. Scans performed prior to liver biopsy were analysed by physicians blinded to the histology results. The associations between magnetic resonance and histology variables were assessed. Receiver-operating characteristic analyses were also carried out.
Results: Paired magnetic resonance and biopsy data were obtained in 79 patients. Magnetic resonance measures correlated strongly with histology (r(s)=0.68 p<0.0001 for fibrosis; r(s)=0.89 p<0.001 for steatosis; r(s)=-0.69 p<0.0001 for haemosiderosis). The area under the receiver operating characteristic curve was 0.94, 0.93, and 0.94 for the diagnosis of any degree of fibrosis, steatosis and haemosiderosis respectively.
Conclusion: The novel scanning method described here provides high diagnostic accuracy for the assessment of liver fibrosis, steatosis and haemosiderosis and could potentially replace liver biopsy for many indications. This is the first demonstration of a non-invasive test to differentiate early stages of fibrosis from normal liver.
Keywords: (1)H MRS; ANOVA; AUROC; Analysis of Variance; Area Under the Receiver Operating Characteristic Curve; BMI; Body Mass Index; CPA; CoV; Coefficient of Variance; Collagen Proportionate Area; HLC; Hepatic Lipid Content; Iron corrected T1; Liver fibrosis; Liver haemosiderosis; Liver steatosis; MR; Magnetic Resonance; Magnetic resonance T1 mapping; Magnetic resonance T2(⁎) mapping; NAFLD; Non-Alcoholic Fatty Liver Disease; Proton Magnetic Resonance Spectroscopy; Proton magnetic resonance spectroscopy; ROI; Region of interest; shMOLLI; shortened Modified Look Locker Inversion.
Copyright © 2013 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
Figures
Similar articles
-
Multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease severity.Liver Int. 2017 Jul;37(7):1065-1073. doi: 10.1111/liv.13284. Epub 2017 May 30. Liver Int. 2017. PMID: 27778429 Free PMC article.
-
Quantitative multiparametric magnetic resonance imaging can aid non-alcoholic steatohepatitis diagnosis in a Japanese cohort.World J Gastroenterol. 2021 Feb 21;27(7):609-623. doi: 10.3748/wjg.v27.i7.609. World J Gastroenterol. 2021. PMID: 33642832 Free PMC article.
-
MRI Dixon Fat-Corrected Look-Locker T1 Mapping for Quantification of Liver Fibrosis and Inflammation-A Comparison With the Non-Fat-Corrected Shortened Modified Look-Locker Inversion Recovery Technique.Invest Radiol. 2024 Nov 1;59(11):754-760. doi: 10.1097/RLI.0000000000001084. Invest Radiol. 2024. PMID: 39514773 Free PMC article.
-
Transient elastography for diagnosis of stages of hepatic fibrosis and cirrhosis in people with alcoholic liver disease.Cochrane Database Syst Rev. 2015 Jan 22;1(1):CD010542. doi: 10.1002/14651858.CD010542.pub2. Cochrane Database Syst Rev. 2015. PMID: 25612182 Free PMC article. Review.
-
Radiologic evaluation of nonalcoholic fatty liver disease.World J Gastroenterol. 2014 Jun 21;20(23):7392-402. doi: 10.3748/wjg.v20.i23.7392. World J Gastroenterol. 2014. PMID: 24966609 Free PMC article. Review.
Cited by
-
Diagnostic accuracy of an uncorrected native T1 mapping sequence for liver fibrosis and inflammation in autoimmune hepatitis: a prospective study using histopathology as reference standard.Radiol Med. 2024 Oct;129(10):1431-1443. doi: 10.1007/s11547-024-01863-2. Epub 2024 Aug 6. Radiol Med. 2024. PMID: 39106024
-
Suppression of skeletal muscle signal using a crusher coil: A human cardiac (31) p-MR spectroscopy study at 7 tesla.Magn Reson Med. 2016 Mar;75(3):962-72. doi: 10.1002/mrm.25755. Epub 2015 Apr 28. Magn Reson Med. 2016. PMID: 25924813 Free PMC article.
-
Hepatic Steatosis, Rather Than Underlying Obesity, Increases the Risk of Infection and Hospitalization for COVID-19.Front Med (Lausanne). 2021 Mar 29;8:636637. doi: 10.3389/fmed.2021.636637. eCollection 2021. Front Med (Lausanne). 2021. PMID: 33855033 Free PMC article.
-
Multiparametric MRI with MR elastography findings in patients with sinusoidal obstruction syndrome after oxaliplatin-based chemotherapy.Insights Imaging. 2022 Sep 5;13(1):147. doi: 10.1186/s13244-022-01281-w. Insights Imaging. 2022. PMID: 36064860 Free PMC article.
-
Magnetic resonance-based biomarkers in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.Endocrinol Diabetes Metab. 2020 Apr 20;3(4):e00134. doi: 10.1002/edm2.134. eCollection 2020 Oct. Endocrinol Diabetes Metab. 2020. PMID: 33102797 Free PMC article. Review.
References
-
- Blachier M., Leleu H., Peck-Radosavljevic M., Valla D.-C., Roudot-Thoraval F. The burden of liver disease in Europe: a review of available epidemiological data. J Hepatol. 2013;58:593–608. - PubMed
-
- Younossi Z.M., Stepanova M., Afendy M., Fang Y., Younossi Y., Mir H. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol. 2011;9:524–530. - PubMed
-
- Poynard T., Lenaour G., Vaillant J.C., Capron F., Munteanu M., Eyraud D. Liver biopsy analysis has a low level of performance for diagnosis of intermediate stages of fibrosis. Clin Gastroenterol Hepatol. 2012;10:657–663. - PubMed
-
- Tsochatzis E.A., Gurusamy K.S., Ntaoula S., Cholongitas E., Davidson B.R., Burroughs A.K. Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a meta-analysis of diagnostic accuracy. J Hepatol. 2011;54:650–659. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical